Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adenylate kinase 2 expression and addiction in T-ALL.
Maslah N, Latiri M, Asnafi V, Féroul M, Bedjaoui N, Steimlé T, Six E, Verhoyen E, Macintyre E, Lagresle-Peyrou C, Lhermitte L, Andrieu GP. Maslah N, et al. Blood Adv. 2021 Feb 9;5(3):700-710. doi: 10.1182/bloodadvances.2020002700. Blood Adv. 2021. PMID: 33560378 Free PMC article.
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.
Debureaux PE, Cassinat B, Soret-Dulphy J, Mora B, Verger E, Maslah N, Plessier A, Rautou PE, Ollivier-Hourman I, De Ledinghen V, Goria O, Bureau C, Siracusa C, Valla D, Giraudier S, Passamonti F, Kiladjian JJ. Debureaux PE, et al. Among authors: maslah n. Blood Adv. 2020 Aug 11;4(15):3708-3715. doi: 10.1182/bloodadvances.2020002414. Blood Adv. 2020. PMID: 32777065 Free PMC article.
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.
Marcault C, Zhao LP, Maslah N, Verger E, Daltro de Oliveira R, Soret-Dulphy J, Cazaux M, Gauthier N, Roux B, Clappier E, Parquet N, Dosquet C, Réa D, Zini JM, Vainchenker W, Raffoux E, Giraudier S, Kiladjian JJ, Cassinat B, Benajiba L. Marcault C, et al. Among authors: maslah n. Blood. 2021 Nov 25;138(21):2142-2148. doi: 10.1182/blood.2020010402. Blood. 2021. PMID: 33945619 Free article. No abstract available.
Clonal evolution in hereditary thrombocytosis with MPL T487A mutation.
Vasseur L, Favier R, Kim R, Rabian F, Cabannes-Hamy A, Cassinat B, Maslah N, Vasquez N, Clappier E, Kiladjian JJ, Boissel N. Vasseur L, et al. Among authors: maslah n. Pediatr Blood Cancer. 2023 Feb;70(2):e29905. doi: 10.1002/pbc.29905. Epub 2022 Aug 4. Pediatr Blood Cancer. 2023. PMID: 35924408 No abstract available.
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia.
Maslah N, Salomao N, Drevon L, Verger E, Partouche N, Ly P, Aubin P, Naoui N, Schlageter MH, Bally C, Miekoutima E, Rahmé R, Lehmann-Che J, Ades L, Fenaux P, Cassinat B, Giraudier S. Maslah N, et al. Haematologica. 2020 Jun;105(6):1539-1551. doi: 10.3324/haematol.2019.218453. Epub 2019 Sep 5. Haematologica. 2020. PMID: 31488557 Free PMC article.
29 results